Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartmann

Showing results (461-470 of 626) with videos related to

Pageof 63
Sort By:
Human Pathology|January 31, 2016
Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 casesAnnie L Meares, Ryan D Frank, Amy C Degnim, et al.
Skeletal Radiology|November 28, 2014
MRI features of the anterolateral ligament of the kneeAtul K Taneja, Frederico C Miranda, Cesar A P Braga, et al.
Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.
Journal of Nutrition Education and Behavior|May 7, 2008
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companionsHeidi McKean, Sherry Looker, Lynn C Hartmann, et al.
Thrombosis Research|August 9, 2015
Reliability of diagnosing incidental pulmonary embolism in cancer patientsPaul L den Exter, Tom van der Hulle, Ieneke J C Hartmann, et al.
Chemosphere|January 9, 2007
The historical record of PCB and PCDD/F deposition at Greifensee, a lake of the Swiss plateau, between 1848 and 1999Markus Zennegg, Martin Kohler, Paul C Hartmann, et al.
British Journal of Cancer|May 12, 2011
PROX1 is a predictor of survival for gliomas WHO grade IIT Elsir, M Qu, S G Berntsson, et al.
Cancer Research|May 19, 2001
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancerV Shridhar, K C Bible, J Staub, et al.
Australian Endodontic Journal : the Journal of the Australian Society of Endodontology Inc|August 15, 2018
Antimicrobial efficacy of 0.5% peracetic acid and EDTA with passive ultrasonic or manual agitation in an Enterococcus faecalis biofilm modelRafael C Hartmann, Lilian Neuvald, Valdir Barth, et al.
Gynecologic Oncology|May 5, 2009
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancerJeremy Chien, Jian-Bing Fan, Debra A Bell, et al.
Pageof 63

Showing results (461-470 of 626) with videos related to

Sort By:
Pageof 63
Human Pathology|January 31, 2016
Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 casesAnnie L Meares, Ryan D Frank, Amy C Degnim, et al.
Skeletal Radiology|November 28, 2014
MRI features of the anterolateral ligament of the kneeAtul K Taneja, Frederico C Miranda, Cesar A P Braga, et al.
Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.
Journal of Nutrition Education and Behavior|May 7, 2008
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companionsHeidi McKean, Sherry Looker, Lynn C Hartmann, et al.
Thrombosis Research|August 9, 2015
Reliability of diagnosing incidental pulmonary embolism in cancer patientsPaul L den Exter, Tom van der Hulle, Ieneke J C Hartmann, et al.
Chemosphere|January 9, 2007
The historical record of PCB and PCDD/F deposition at Greifensee, a lake of the Swiss plateau, between 1848 and 1999Markus Zennegg, Martin Kohler, Paul C Hartmann, et al.
British Journal of Cancer|May 12, 2011
PROX1 is a predictor of survival for gliomas WHO grade IIT Elsir, M Qu, S G Berntsson, et al.
Cancer Research|May 19, 2001
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancerV Shridhar, K C Bible, J Staub, et al.
Australian Endodontic Journal : the Journal of the Australian Society of Endodontology Inc|August 15, 2018
Antimicrobial efficacy of 0.5% peracetic acid and EDTA with passive ultrasonic or manual agitation in an Enterococcus faecalis biofilm modelRafael C Hartmann, Lilian Neuvald, Valdir Barth, et al.
Gynecologic Oncology|May 5, 2009
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancerJeremy Chien, Jian-Bing Fan, Debra A Bell, et al.
Pageof 63